Literature DB >> 28420458

Potentially important periods of change in the development of social and role functioning in youth at clinical high risk for psychosis.

Eva Velthorst1, Jamie Zinberg2, Jean Addington3, Kristin S Cadenhead4, Tyrone D Cannon5, Ricardo E Carrión6, Andrea Auther6, Barbara A Cornblatt6, Thomas H McGlashan5, Daniel H Mathalon7, Diana O Perkins8, Larry J Seidman9, Ming T Tsuang4, Elaine F Walker10, Scott W Woods5, Abraham Reichenberg1, Carrie E Bearden2.   

Abstract

The developmental course of daily functioning prior to first psychosis-onset remains poorly understood. This study explored age-related periods of change in social and role functioning. The longitudinal study included youth (aged 12-23, mean follow-up years = 1.19) at clinical high risk (CHR) for psychosis (converters [CHR-C], n = 83; nonconverters [CHR-NC], n = 275) and a healthy control group (n = 164). Mixed-model analyses were performed to determine age-related differences in social and role functioning. We limited our analyses to functioning before psychosis conversion; thus, data of CHR-C participants gathered after psychosis onset were excluded. In controls, social and role functioning improved over time. From at least age 12, functioning in CHR was poorer than in controls, and this lag persisted over time. Between ages 15 and 18, social functioning in CHR-C stagnated and diverged from that of CHR-NC, who continued to improve (p = .001). Subsequently, CHR-C lagged behind in improvement between ages 21 and 23, further distinguishing them from CHR-NC (p < .001). A similar period of stagnation was apparent for role functioning, but to a lesser extent (p = .007). The results remained consistent when we accounted for the time to conversion. Our findings suggest that CHR-C start lagging behind CHR-NC in social and role functioning in adolescence, followed by a period of further stagnation in adulthood.

Entities:  

Mesh:

Year:  2017        PMID: 28420458      PMCID: PMC5648633          DOI: 10.1017/S0954579417000451

Source DB:  PubMed          Journal:  Dev Psychopathol        ISSN: 0954-5794


  43 in total

1.  Case history data and prognosis in schizophrenia.

Authors:  L PHILLIPS
Journal:  J Nerv Ment Dis       Date:  1953-06       Impact factor: 2.254

Review 2.  Social functioning as an outcome measure in schizophrenia studies.

Authors:  T Burns; D Patrick
Journal:  Acta Psychiatr Scand       Date:  2007-10-17       Impact factor: 6.392

3.  When and how does schizophrenia produce social deficits?

Authors:  H Häfner; B Nowotny; W Löffler; W an der Heiden; K Maurer
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1995       Impact factor: 5.270

4.  Development of a group and family-based cognitive behavioural therapy program for youth at risk for psychosis.

Authors:  Yulia Landa; Kim T Mueser; Katarzyna E Wyka; Erica Shreck; Rachel Jespersen; Michael A Jacobs; Kenneth W Griffin; Mark van der Gaag; Valerie F Reyna; Aaron T Beck; David A Silbersweig; John T Walkup
Journal:  Early Interv Psychiatry       Date:  2015-01-13       Impact factor: 2.732

5.  The "Right Stuff" Revisited: What Have We Learned About the Determinants of Daily Functioning in Schizophrenia?

Authors:  Michael F Green; Katiah Llerena; Robert S Kern
Journal:  Schizophr Bull       Date:  2015-03-07       Impact factor: 9.306

Review 6.  Psychotherapy for adolescents and young adults at high risk for psychosis: a systematic review.

Authors:  Nana Okuzawa; Emily Kline; Janine Fuertes; Shobhit Negi; Gloria Reeves; Seth Himelhoch; Jason Schiffman
Journal:  Early Interv Psychiatry       Date:  2014-02-27       Impact factor: 2.732

7.  Baseline differences in clinical symptomatology between ultra high risk subjects with and without a transition to psychosis.

Authors:  Eva Velthorst; Dorien H Nieman; Hiske E Becker; Reinaud van de Fliert; Peter M Dingemans; Rianne Klaassen; Lieuwe de Haan; Thérèse van Amelsvoort; Don H Linszen
Journal:  Schizophr Res       Date:  2009-03-09       Impact factor: 4.939

Review 8.  A neurodevelopmental approach to the classification of schizophrenia.

Authors:  R M Murray; E O'Callaghan; D J Castle; S W Lewis
Journal:  Schizophr Bull       Date:  1992       Impact factor: 9.306

9.  Premorbid functioning of patients with first-episode nonaffective psychosis: a comparison of deterioration in academic and social performance, and clinical correlates of Premorbid Adjustment Scale scores.

Authors:  Ralph C Monte; Sandra M Goulding; Michael T Compton
Journal:  Schizophr Res       Date:  2008-07-26       Impact factor: 4.939

10.  The Premorbid Adjustment Scale as a measure of developmental compromise in patients with schizophrenia and their healthy siblings.

Authors:  D I Shapiro; S Marenco; E H Spoor; M F Egan; D R Weinberger; J M Gold
Journal:  Schizophr Res       Date:  2009-05-01       Impact factor: 4.939

View more
  11 in total

1.  Early childhood social communication deficits in youth at clinical high-risk for psychosis: Associations with functioning and risk.

Authors:  K Juston Osborne; Teresa Vargas; Vijay A Mittal
Journal:  Dev Psychopathol       Date:  2020-05

2.  The relationship between stress responding in family context and stress sensitivity with sleep dysfunction in individuals at clinical high-risk for psychosis.

Authors:  Ivanka Ristanovic; Claudia M Haase; Jessica R Lunsford-Avery; Vijay A Mittal
Journal:  J Psychiatr Res       Date:  2022-03-02       Impact factor: 5.250

3.  Age-related trajectories of social cognition in youth at clinical high risk for psychosis: An exploratory study.

Authors:  Charlie A Davidson; Danijela Piskulic; Jean Addington; Kristen S Cadenhead; Tyrone D Cannon; Barbara A Cornblatt; Thomas H McGlashan; Diana O Perkins; Larry J Seidman; Ming T Tsuang; Elaine F Walker; Carrie E Bearden; Daniel H Mathalon; Scott W Woods; Jason K Johannesen
Journal:  Schizophr Res       Date:  2018-05-08       Impact factor: 4.939

4.  The Global Functioning: Social and Role Scales-Further Validation in a Large Sample of Adolescents and Young Adults at Clinical High Risk for Psychosis.

Authors:  Ricardo E Carrión; Andrea M Auther; Danielle McLaughlin; Ruth Olsen; Jean Addington; Carrie E Bearden; Kristin S Cadenhead; Tyrone D Cannon; Daniel H Mathalon; Thomas H McGlashan; Diana O Perkins; Larry J Seidman; Ming T Tsuang; Elaine F Walker; Scott W Woods; Barbara A Cornblatt
Journal:  Schizophr Bull       Date:  2019-06-18       Impact factor: 9.306

5.  Prognostic Accuracy of DSM-5 Attenuated Psychosis Syndrome in Adolescents: Prospective Real-World 5-Year Cohort Study.

Authors:  Martina Maria Mensi; Silvia Molteni; Melanie Iorio; Eleonora Filosi; Elena Ballante; Umberto Balottin; Paolo Fusar-Poli; Renato Borgatti
Journal:  Schizophr Bull       Date:  2021-10-21       Impact factor: 9.306

6.  Family-focused therapy for individuals at high clinical risk for psychosis: A confirmatory efficacy trial.

Authors:  David J Miklowitz; Jean M Addington; Mary P O'Brien; Danielle M Denenny; Marc J Weintraub; Jamie L Zinberg; Daniel H Mathalon; Barbara A Cornblatt; Michelle S Friedman-Yakoobian; William S Stone; Kristin S Cadenhead; Scott W Woods; Catherine A Sugar; Tyrone D Cannon; Carrie E Bearden
Journal:  Early Interv Psychiatry       Date:  2021-08-23       Impact factor: 2.721

7.  Using Online Screening in the General Population to Detect Participants at Clinical High-Risk for Psychosis.

Authors:  Mhairi McDonald; Eleni Christoforidou; Nicola Van Rijsbergen; Ruchika Gajwani; Joachim Gross; Andrew I Gumley; Stephen M Lawrie; Matthias Schwannauer; Frauke Schultze-Lutter; Peter J Uhlhaas
Journal:  Schizophr Bull       Date:  2019-04-25       Impact factor: 9.306

8.  Associations of psychotic-like experiences, related symptoms, and working memory with functioning.

Authors:  Charlotte A Chun; Shanna Cooper; Lauren M Ellman
Journal:  Eur Psychiatry       Date:  2020-02-24       Impact factor: 5.361

Review 9.  Advances in clinical staging, early intervention, and the prevention of psychosis.

Authors:  Tina Gupta; Vijay A Mittal
Journal:  F1000Res       Date:  2019-11-29

10.  DSM-5 Attenuated Psychosis Syndrome in Adolescents Hospitalized With Non-psychotic Psychiatric Disorders.

Authors:  Gonzalo Salazar de Pablo; Daniel Guinart; Barbara A Cornblatt; Andrea M Auther; Ricardo E Carrión; Maren Carbon; Sara Jiménez-Fernández; Ditte L Vernal; Susanne Walitza; Miriam Gerstenberg; Riccardo Saba; Nella Lo Cascio; Martina Brandizzi; Celso Arango; Carmen Moreno; Anna Van Meter; Paolo Fusar-Poli; Christoph U Correll
Journal:  Front Psychiatry       Date:  2020-10-21       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.